Shares of UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) hit a new 52-week high during trading on Friday after Oppenheimer raised their price target on the stock from $22.00 to $33.00. The stock traded as high as $23.38 and last traded at $22.68, with a volume of 4657877 shares trading hands. The stock had […]
UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report)’s stock price reached a new 52-week high on Friday after Oppenheimer raised their price target on the stock from $22.00 to $33.00. The company traded as high as $23.38 and last traded at $22.68, with a volume of 4657877 shares. The stock had previously closed at $17.89. […]
UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 909,100 shares, a growth of 38.5% from the June 15th total of 656,300 shares. Approximately 4.6% of the shares of the company are sold short. Based […]
The following discussion contains management s discussion and analysis of our
financial condition and results of operations and should be read together with
the historical consolidated financial. | March 24, 2023